Hypersensitivity of BRCA2 deficient cells to rosemary extract explained by weak PARP inhibitory activity
Abstract Rosemary extract is used in food additives and traditional medicine and has been observed to contain anti-tumor activity. In this study, rosemary extract is hypothesized to induce synthetic lethality in BRCA2 deficient cells by PARP inhibition. Chinese hamster lung V79 cells and its mutant...
Guardado en:
Autores principales: | Cathy Su, Jeffrey P. Gius, Julia Van Steenberg, Alexis H. Haskins, Kazuki Heishima, Chisato Omata, Masahiro Iwayama, Mami Murakami, Takashi Mori, Kohji Maruo, Takamitsu A. Kato |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7565a82dd66f49b1a36dd312937e9dcc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
por: Xia Ding, et al.
Publicado: (2016) -
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
por: Diar Aziz, et al.
Publicado: (2021) -
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
por: Yifan Wang, et al.
Publicado: (2019) -
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors
por: Timo Reisländer, et al.
Publicado: (2019) -
Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease
por: Kazuki Heishima, et al.
Publicado: (2017)